TAVABOROLE
| Brand name | TAVABOROLE |
|---|---|
| Active ingredient | TAVABOROLE |
| Strength | 5% |
| Dosage form | SOLUTION |
| Route | TOPICAL |
| Modality | Small molecule |
| FDA approval | February 2021 |
| Marketing status | DISCN |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.